Mallinckrodt Denies Manipulating Acthar Market
Mallinckrodt closed its defense against claims it inflated the price of its Acthar gel on Wednesday, with witnesses saying that the drugmaker didn't suppress a competing product and that the speaking fees...To view the full article, register now.
Already a subscriber? Click here to view full article